8-K - Aligos Therapeutics, Inc. - 1.01

Form 8-K - Current report: SEC Accession No. 0001193125-26-166987

Filing Date: 2026-04-21

Accepted: 2026-04-21 16:32:46

Documents: 11

Period of Report: 2026-04-16

Items: Item 1.01: Entry into a Material Definitive Agreement

Aligos Therapeutics, Inc. (Filer) CIK : 0001799448 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39617 | Film No.: 26879979 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)

1 | 8-K | d50981d8k.htm iXBRL | 8-K

2 | XBRL TAXONOMY EXTENSION SCHEMA | algs-20260416.xsd | EX-101.SCH

3 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | algs-20260416_lab.xml | EX-101.LAB

4 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | algs-20260416_pre.xml | EX-101.PRE